Efficacy of intravenous iron for restless legs syndrome-moving beyond monotherapy and into the "real world"

Elie Matar^{1

2

3}, Nathaniel S Marshall^{1

4}, Brendon J Yee^{1

2

5}

Affiliations

¹ Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute for Medical Research, Sydney NSW, Australia.
² Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney NSW,Australia.
³ Department of Neurology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney NSW, Australia.
⁴ Department of Health Sciences, Macquarie University, Sydney NSW, Australia.
⁵ Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney NSW, Australia.

Editorial

Elie Matar et al. Sleep. 2024.

. 2024 Jul 11;47(7):zsae022.

doi: 10.1093/sleep/zsae022.

Elie Matar^{1

2

3}, Nathaniel S Marshall^{1

4}, Brendon J Yee^{1

2

5}

¹ Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute for Medical Research, Sydney NSW, Australia.
² Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney NSW,Australia.
³ Department of Neurology, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney NSW, Australia.
⁴ Department of Health Sciences, Macquarie University, Sydney NSW, Australia.
⁵ Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney Local Health District, Sydney NSW, Australia.

No abstract available

Comment on

Disrupted topological properties of structural brain networks present a glutamatergic neuropathophysiology in people with narcolepsy.
Chen G, Wang W, Wu H, Zhao X, Kang X, Ren J, Zhang J, Sun Y, He J, Sun S, Zhong Z, Shang D, Fan M, Cheng J, Zhang D, Su C, Lin J. Chen G, et al. Sleep. 2024 Jun 13;47(6):zsae002. doi: 10.1093/sleep/zsae002. Sleep. 2024. PMID: 38173348
White matter integrity in narcolepsy: the structural blueprint for functional complaints?
Gool JK, Dang-Vu TT, van der Werf YD. Gool JK, et al. Sleep. 2024 Jun 13;47(6):zsae020. doi: 10.1093/sleep/zsae020. Sleep. 2024. PMID: 38263318 Free PMC article. No abstract available.

1. Manconi M, Garcia-Borreguero D, Schormair B, et al. Restless legs syndrome. Nat Rev Dis Primers. 2021;7(1):80. doi: 10.1038/s41572-021-00311-z - DOI - PubMed
1. Winkelman JW. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome. Sleep. 2022;45(2). doi: 10.1093/sleep/zsab212 - DOI - PMC - PubMed
1. Buchfuhrer MJ. Strategies for the treatment of restless legs syndrome. Neurotherapeutics. 2012;9(4):776–790. doi: 10.1007/s13311-012-0139-4 - DOI - PMC - PubMed
1. Silber MH, Buchfuhrer MJ, Earley CJ, Koo BB, Manconi M, Winkelman JW; Scientific and Medical Advisory Board of the Restless Legs Syndrome Foundation. The management of restless legs syndrome: an updated algorithm. Mayo Clin Proc. 2021;96(7):1921–1937. doi: 10.1016/j.mayocp.2020.12.026 - DOI - PubMed
1. Trotti LM, Becker LA.. Iron for the treatment of restless legs syndrome. Cochrane Database Syst Rev. 2019;1(1):CD007834. doi: 10.1002/14651858.CD007834.pub3 - DOI - PMC - PubMed